Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2049-2013Class II

SARKEN STAT! Multi-Drug Test Panel Product Usage- Labeled as FOR FORENSIC USE ONLY (Employee, Student or...

Sarken, Inc. / initiated 2013-07-29 / Terminated / root cause: labeling and UDI

Sarken, Inc. began a recall of SARKEN STAT! Multi-Drug Test Panel Product Usage- Labeled as FOR FORENSIC USE ONLY (Employee, Student or Probation Testing) on . FDA classified it as Class II and gives the reason as "These products are being recalled because they were distributed without adequate labeling and instructions for use. Inadequate labeling could lead to misuse of the Test Kits and incorrect test results". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2049-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Sarken, Inc.
Product
SARKEN STAT! Multi-Drug Test Panel Product Usage- Labeled as FOR FORENSIC USE ONLY (Employee, Student or Probation Testing).
Product code
DKZ Enzyme Immunoassay, Amphetamine
Reason for recall
These products are being recalled because they were distributed without adequate labeling and instructions for use. Inadequate labeling could lead to misuse of the Test Kits and incorrect test results.
Root cause tag
labeling and UDI
FDA root cause
Other
Action
Firm notified customers via telephone, followed up with MEDICAL DEVICE RECALL letter dated July 29, 2013 sent 08/02/13, via USPS regular mail to all affected customers. The recall notification letter is accompanied by a return response, acknowledgement and receipt form. The letter notify customers of the voluntary recall, product description (with prodcut images), reason for recall, potential impact, instructions/actions to follow, and contact information.
Quantity in commerce
various quantities
Distribution
Worldwide Distribution - US Nationwide in the country Virgin Islands
Product codes and lots
Manufacturer's Product Number DOA-254  Lot Number DOA2050035 DOA2090666 DOA2110059 DOA2120771  Expiration Date: 02/2014 07/2014 08/2014 10/2014

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2049-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2048-2013Class IITerminatedVoluntary: Firm initiated
Z-2049-2013Class IITerminatedVoluntary: Firm initiated
Z-2050-2013Class IITerminatedVoluntary: Firm initiated
Z-2051-2013Class IITerminatedVoluntary: Firm initiated
Z-2052-2013Class IITerminatedVoluntary: Firm initiated
Z-2053-2013Class IITerminatedVoluntary: Firm initiated